{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:49:55Z","timestamp":1761518995519},"reference-count":24,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":9885,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Scandinavian Journal of Haematology"],"published-print":{"date-parts":[[1982,4]]},"abstract":"<jats:p>The serum concentration of free kappa and lambda light chains of immunoglobulins was measured in 114 patients with myelo\u2010 and lymphoproliferative disorders including multiple myeloma. Increased concentrations of a single light chain type, suggesting monoclonal origin, were found with high frequency in B\u2010cell diseases only. Thus 6 out of 9 patients with chronic lymphatic leukaemia and 24 of 28 patients with multiple myeloma had increased concentrations of a single chain type. The highest values reported in chronic lymphatic leukaemia were approximately 10 and in multiple myeloma 1000 times normal mean. Cytostatic treatment of chronic lymphatic leukaemia was followed by a decrease in the light chain levels. The levels were, however, not correlated to the number of circulating lymphocytes, the lymphatic infiltration of tissue or clinical activity. Increased concentrations of both chain types, suggesting a polyclonal origin, were found in both of 2 patients with acute monocytic leukaemia, 6 of 7 with acute myelomonocytic leukaemia, 2 of 23 with acute myeloid leukaemia and 1 of 7 with acute lymphoblastic leukaemia. The highest levels of light chains in these groups were 5 times normal mean. All patients with myeloproliferative disorders revealed normal values of both light chain types.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1982.tb00532.x","type":"journal-article","created":{"date-parts":[[2010,8,3]],"date-time":"2010-08-03T10:00:30Z","timestamp":1280829630000},"page":"309-318","source":"Crossref","is-referenced-by-count":19,"title":["Free Light Chains of Immunoglobulins in Serum from Patients with Leukaemias and Multiple Myeloma"],"prefix":"10.1111","volume":"28","author":[{"given":"K.","family":"S\u00f8lling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Lanng","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"S\u00f8lling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ellegaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197307)32:1<121::AID-CNCR2820320116>3.0.CO;2-C"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/216264a0"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197909)44:3<927::AID-CNCR2820440321>3.0.CO;2-O"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1976.tb03563.x"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1974.tb00445.x"},{"key":"e_1_2_1_7_1","first-page":"145","article-title":"Proposed guidelines for protocol studies. II. Plasma cell myeloma","volume":"4","author":"Comittee of the Chronic Leukaemia\u2010Myeloma Task Force, National Cancer Institute","year":"1973","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_1_8_1","first-page":"911","article-title":"Serum and urine light chain levels in benign monoclonal gamma\u2010pathies, multiple myeloma and Waldenstroms macroglobulinemia","volume":"3","author":"Dammaco F.","year":"1968","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1981.tb01401.x"},{"key":"e_1_2_1_10_1","first-page":"397","article-title":"Free light chain synthesis by neoplastic cells in chronic lymphocytic leukaemia and non\u2010Hodgkin's lymphoma","volume":"34","author":"Gordon J.","year":"1978","journal-title":"Immunology"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2423(08)60147-X"},{"key":"e_1_2_1_12_1","volume-title":"The Monoclonal Gammopathies. Multiple Myeloma and Related Plasma\u2010Cell Disorders.","author":"Kyle R. A.","year":"1976"},{"key":"e_1_2_1_13_1","first-page":"83","article-title":"Urinary light chain excretion in leukaemia and lymphoma","volume":"5","author":"Lindstr\u00f8tn F. D.","year":"1969","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_1_14_1","doi-asserted-by":"crossref","first-page":"742","DOI":"10.4049\/jimmunol.118.3.742","article-title":"Mitogen activation of human chronic lymphatic leukemia cells. I. Synthesis and secretion of immunoglobulin","volume":"118","author":"Maino V. C.","year":"1977","journal-title":"J Immunol"},{"key":"e_1_2_1_15_1","doi-asserted-by":"crossref","unstructured":"McLaughlin&HobbsJ. R.(1972)Clinical significance of Bence\u2010Jones Proteinuria. InH.Peeters(ed)Pro\u2010tides of the Biological Fluids 20th Colloquium pp251\u201354.","DOI":"10.1136\/jcp.25.6.555-e"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365517709101835"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2423(08)60389-3"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V46.2.219.219"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/211243a0"},{"key":"e_1_2_1_20_1","first-page":"447","article-title":"Free light chains of immunoglobulins in normal serum and urine determined by radioimmunoassay","volume":"37","author":"S\u00f8lling K.","year":"1975","journal-title":"Scand J Clin Lab Invest"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365517709108798"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365517809108436"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1981.tb11632.x"},{"key":"e_1_2_1_24_1","first-page":"290","volume-title":"Basic and Clinical Immunology","author":"Wells J. V.","year":"1976"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197102182840704"}],"container-title":["Scandinavian Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1982.tb00532.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1982.tb00532.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T18:34:58Z","timestamp":1699468498000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1982.tb00532.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1982,4]]}},"alternative-id":["10.1111\/j.1600-0609.1982.tb00532.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1982.tb00532.x","archive":["Portico"],"relation":{},"ISSN":["0036-553X"],"issn-type":[{"value":"0036-553X","type":"print"}],"subject":[],"published":{"date-parts":[[1982,4]]}}}